UBS Group AG - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is and the CUSIP is 87164U409. A total of 26 filers reported holding SYNTHETIC BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q2 2023$5,933
+157.2%
5,933
+18.3%
0.00%
Q4 2022$2,307
-67.0%
5,015
-25.9%
0.00%
Q3 2022$7,0006,7660.00%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
BRIDGEWAY CAPITAL MANAGEMENT, LLC 28,528$19,9240.00%
Renaissance Technologies 34,710$240.00%
ROYAL BANK OF CANADA 7$00.00%
VANGUARD GROUP INC 525,367$366,9160.00%
IFP Advisors, Inc 382$5720.00%
OSAIC HOLDINGS, INC. 47$320.00%
BANK OF AMERICA CORP /DE/ 21$140.00%
WELLS FARGO & COMPANY/MN 110$770.00%
NORTHERN TRUST CORP 35,699$24,9320.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SYNTHETIC BIOLOGICS INC shareholders